Stephen Hahn

WASHINGTON, DC - AUGUST 23: FDA Commissioner Stephen Hahn looks on as President Donald Trump announces that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment during a press conference in James S. Brady Briefing Room at the White House on on August 23, 2020 in Washington, DC. The move by the FDA comes after President Trump accused the FDA of slow-walking the therapy to harm his reelection chances.(Photo by Pete Marovich/Getty Images) ‘Untrue Representation’: FDA Chief Denies WH Pressured Him Into Approving Vaccine
By | December 13, 2020 3:50 p.m.
Navarro Dismisses Criticism Of Plasma Treatment For COVID-19 As ‘Crazy Talking Point’
By | August 25, 2020 1:43 p.m.
FDA Chief Admits He Overhyped Plasma Treatment Against COVID: ‘Criticism Is Entirely Justified’
By | August 25, 2020 8:31 a.m.
FDA Chief Won’t Refute Trump’s Claim That 99% Of Coronavirus Cases Are ‘Harmless’
By | July 5, 2020 10:08 a.m.
It’s Been Weeks Since Top Public Health Officials Have Spoken To Trump
By | June 23, 2020 5:09 p.m.
FDA Commissioner: ‘Too Early’ To Say Whether Economy Should Reopen In May
By | April 12, 2020 1:55 p.m.
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Deputy Editor:
Investigations Desk:
Reporters:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: